Journal
ELIFE
Volume 12, Issue -, Pages -Publisher
eLIFE SCIENCES PUBL LTD
DOI: 10.7554/eLife.91831
Keywords
doxorubicin; cardiotoxicity; EPAC1; cancer survivorship; Human; Mouse; Rat
Categories
Ask authors/readers for more resources
Blocking protein EPAC1 can potentially halt the progression of chemotherapy-induced heart-related side effects.
Blocking a protein known as EPAC1 may prevent the development of heart-related side effects caused by a chemotherapy drug.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
